podcasts forums register add a podcast

PeerView CME/CE Audio Podcast - Rheumatology

PeerView Press is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

Episodes:	50
Updated:	9 months ago (login to update)
Categories:	*Science & Medicine*

Joel M. Kremer, MD - Safety Update of Newer Biologics in Refractory Rheumatoid Arthritis

Published: 9 months ago
Size: 30.5MB

In this activity, experts in the treatment of rheumatoid arthritis (RA) discuss updated safety data associated with the use of abatacept or rituximab in methotrexate- or TNF-antagonist–refractory RA.

CME/CE Information - Safety Update of Newer Biologics in Refractory Rheumatoid Arthritis

unknown filetype: pdf
Published: 9 months ago
Size: 257.0KB

Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file.

Paul Emery, MD, FRCP - Long-Term Efficacy of Newer Biologics in Refractory Rheumatoid Arthritis

Published: 9 months ago
Size: 23.1MB

In this activity, experts in the treatment of rheumatoid arthritis discuss recent data on the use of abatacept and rituximab in methotrexate- or TNF-antagonist–refractory rheumatoid arthritis.

CME/CE Information - Long-Term Efficacy of Newer Biologics in Refractory Rheumatoid Arthritis

unknown filetype: pdf
Published: 9 months ago
Size: 277.1KB

Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file.

Mark Genovese, MD - Clinical Update on Biologic Treatment Options for Rheumatoid Arthritis

Published: 10 months ago
Size: 31.2MB

In this CME activity, experts provide an update on the latest data on efficacy and safety of current and novel biologic therapies for rheumatoid arthritis (RA). Additionally, the activity will provide information from new RA treatment guidelines intended to help physicians understand when to start nonbiologic and biologic therapies in RA.

5 of 50 episodes displayed
View All Episodes >
(45 more)

Comments

- no comments found -

Login to post a comment